Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies

Lifetime Data Analysis

Volumn 14, Issue 1, 2008, Pages 18-36

  Gail, Mitchell H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Absolute risk; Calibration; Cumulative incidence; Discriminatory accuracy; Family based design

Indexed keywords

ARTICLE; BIOMETRY; FAMILY; HUMAN; POPULATION AND POPULATION RELATED PHENOMENA; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS;

BIOMETRY; EPIDEMIOLOGIC MEASUREMENTS; FAMILY; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; RISK ASSESSMENT;

EID: 39149117080     PISSN: 13807870     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10985-007-9070-0     Document Type: Article

References (54)

1. Albertsen PC, Hanley JA and Fine J (2005). 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293: 2095-2101
2. Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ and Easton D (2001). Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21: 1-18
3. Antoniou AC, Pharoah PDP and McMullan G et al (2002). A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J of Cancer 86: 76-83
4. Antoniou A, Pharoah PDP and Narod S et al (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130
5. Antoniou AC, Pharoah PPD, Smith P and Easton DF (2004). The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91: 1580-1590
6. Begg CB (2002). On the use of familial aggregation in population-based case probands for calculating penetrance. J Nat Cancer Inst 94: 1221-1226
7. Berry DA, Parmigiani G, Sanchez J, Schildkraut J and Winer E (1997). Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89: 227-238
8. Berry DA, Iversen ES and Gudbjartsson DF et al (2002). BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20: 2701-2712
9. Brookmeyer R and Gail MH (1988). A method for obtaining short-term projections and lower bounds on the size of the AIDS epidemic. J Am Stat Assoc 83: 301-308
10. Chatterjee N and Wacholder S (2001). A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 57: 245-252
11. Chatterjee N, Hartge P and Wacholder S (2003). Adjustment for competing risk in kin-cohort estimation. Genet Epidemiol 25: 303-313
12. Chatterjee N, Kalaylioglu Z, Shih JH and Gail MH (2006). Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk. Biometrics 62: 36-48
13. Chen JB, Pee D and Ayyagari R et al (2006). Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 98: 1215-1226
14. Claus EB, Risch N and Thompson WD (1991). Genetic-analysis of breast-cancer in the Cancer and Steroid-Hormone Study. Am J Hum Genet 48: 232-242
15. Claus EB, Risch N and Thompson WD (1994). Autosomal-dominant inheritance of early-onset breast-cancer - implications for risk prediction. Cancer 73: 643-651
16. Claus EB, Schildkraut J, Iversen ES, Berry D and Parmigiani G (1998). Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst 90: 1824-1829
17. Costantino JP, Gail MH and Pee D et al (1999). Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91: 1541-1548
18. Cox A, Dunning AM and Garcia-Closas M et al (2007). A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39: 352-358
19. Easton DF, Ford D and Bishop DT et al (1995). Breast and ovarian -cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56: 265-271
20. Easton DF, Pooley KA and Dunning AM et al (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1095
21. Fine JP and Gray RJ (1999). A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509
22. Fisher RA (1918). The correlation between reatives on the supposition of Mendelian inheritance. Trans R Soc Edinburgh 52: 399-433
23. Ford D, Easton DF and Stratton M et al (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62: 676-689
24. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R and Gail MH (2003). Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95: 526-532
25. Gail MH (2008). Models of absolute risk: interpretation, estimation,validation and application. In: Rebbeck, TR, Ambrosone, CB and Shields, PG (eds) Molecular epidemiology in Cancer, Informa Healthcare USA, Inc, New York (in press)
26. Gail M and Chatterjee N (2004). Some biases that may affect kin-cohort studies for estimating the risks from identified disease genes. In: Lin, DY and Haegerty, PJ (eds) Proceedings of the second Seattle symposium in biostatistics: analysis of correlated data, pp 175-187. Springer, New York
27. Gail M and Chatterjee N (2008). Estimating the absolute risk of disease associated with identified mutations. In: Lin, S and Zhao, H (eds) Handbook on analyzing human genetic data-computational approaches and software, Springer, New York (in press)
28. Gail MH and Pfeiffer RM (2005). On criteria for evaluating models of absolute risk. Biostatistics 6: 227-239
29. Gail M and Rimer B (1999). Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 17: 740-740
30. Gail MH, Wieand S and Piantadosi S (1984). Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 71: 431-444
31. Gail M H, Brinton LA and Byar DP et al (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Nat Cancer Inst 81: 1879-1886
32. Gail MH, Costantino JP and Bryant J et al (1999a). Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91: 1829-1846
33. Gail MH, Pee D, Benichou J and Carroll R (1999b). Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs. Genet Epidemiol 16: 15-39
34. Gail MH, Pee D and Carroll R (1999c). Kin-cohort designs for gene characterization. In: Seminara, D (eds) Monographs of the Journal of the National Cancer Institute, Number 26: innovative study designs and analytic approaches to the genetic epidemiology of cancer, pp 55-60. Oxford University Press, Cary, NC
35. Gail MH, Pee D and Carroll R (2001). Effects of violations of assumptions on likelihood methods for estimating the penetrance of an autosomal dominant mutation from kin-cohort studies. J Stat Plan Inference 96: 167-177
36. Hunter DJ, Kraft P and Jacobs KB et al (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874
37. Iversen ES and Chen SN (2005). Population-calibrated gene characterization: Estimating age at onset distributions associated with cancer genes. J Am Stat Assoc 100: 399-409
38. John EM, Hopper JL and Beck JC et al (2004). The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6: R375-89
39. Kraft P and Thomas DC (2000). Bias and efficiency in family-based gene-characterization studies: Conditional, prospective, retrospective and joint likelihoods. Am J Hum Genet 66: 1119-1131
40. Langholz B, Borgan O (2003) Estimation of absolute risk from nested case-control data (vol 53, p 767, 1997). Biometrics 59:451-451
41. Mark SD and Katki HA (2006). Specifying and implementing nonparametric and semiparametric survival estimators in two-stage (nested) cohort studies with missing case data. J Am Stat Assoc 101: 460-471
42. Pepe MS, Janes H, Longton G, Leisenring W and Newcomb P (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159: 882-890
43. Pfeiffer RM, Gail MH and Pee D (2001). Inference for covariates that accounts for ascertainment and random genetic effects in family studies. Biometrika 88: 933-948
44. Prentice RL (1986). A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73: 1-11
45. Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT and Breslow NE (1978). Analysis of failure times in presence of competing risks. Biometrics 34: 541-554
46. Risch N (1990). Linkage strategies for genetically complex traits 1 Multilocus models. Am J Hum Genet 46: 222-228
47. Rockhill B, Spiegelman D, Byrne C, Hunter DJ and Colditz GA (2001). Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93: 358-366
48. Self SG and Prentice RL (1988). Asymptotic-distribution theory and efficiency results for case cohort studies. Ann Stat 16: 64-81
49. Struewing JP, Hartge P and Wacholder S et al (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
50. Tsiatis AA (2005). Competing risks. In: Armitage, P and Colton, T (eds) Encyclopedia of biostatistics, pp 1025-1035. John Wiley & Sons Ltd, Chicester England
51. Tyrer J, Duffy SW, Cuzick J (2005) A breast cancer prediction model incorporating familial and personal risk factors (vol 23, p 1111, 2004). Stat Med 24:156-156
52. Wacholder S, Hartge P and Struewing JP et al (1998). The kin-cohort study for estimating penetrance. Am J Epidemiol 148: 623-630
53. Whittemore AS (1997). Logistic regression of family data from case-control studies (vol 82, p 57, 1995). Biometrika 84:989-990
54. Wingo PA, Ory HW, Layde PM and Lee NC (1988). The evaluation of the data-collection process for a multicenter, population-based, case-control design. Am J Epidemiolo 128: 206-217